echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 210 drug reviews!

    210 drug reviews!

    • Last Update: 2022-03-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
     On February 15, Shanghai Sunshine Pharmaceutical Purchasing Network issued the "Notice on Announcement of the First Batch of Generic Drug Quality and Efficacy Consistency Evaluations for Online Purchase in 2022".
    According to the notice, 210 products were reviewed and purchased online, of which 122 pharmaceutical companies including Amoxicillin Capsules of Yuekang Pharmaceutical Group, Omeprazole Enteric-Coated Tablets of Fangsheng Pharmaceutical, Bicalutamide Tablets of Jianghaizheng Pharmaceutical, Linezolid Glucose Injection of Chia Tai Tianqing Pharmaceutical Group 's products
    .
    The content of the notice shows: In accordance with the requirements of the "Notice on Direct Online Purchase of Generic Drugs Quality and Efficacy Consistency Evaluation Varieties" and the "Supplementary Notice on Generic Drug Quality and Efficacy Consistency Evaluation Varieties Going Online", February 2022 On the 15th, drug information will be pushed to medical institutions through the "Shanghai Pharmaceutical Procurement Service and Supervision Information System", and the price negotiation will take effect on February 17, 2022
    .
    After the drug information is released, all drug manufacturers are requested to check the drug information, and if there is any doubt, report it to the Municipal Pharmacy Office in a timely manner
    .
    Among the pharmaceutical companies that have reviewed the products this time, Jiangsu Hansoh Pharmaceutical Group Co.
    , Ltd.
    has reviewed many products, including azacitidine for injection, bivalirudin for injection, decitabine for injection, and pemetrexed for injection.
    Troxet disodium, gemcitabine hydrochloride for injection, vinorelbine tartrate injection, and tigecycline for injection have been reviewed
    .
    In addition, seven batches of Rosuvastatin Calcium Tablets produced by Zhejiang Jiangbei Pharmaceutical Co.
    , Ltd.
    have passed the regulatory evaluation; Comment; Chia Tai Tianqing Pharmaceutical Group Co.
    , Ltd.
    has five batches of Linezolid Glucose Injection, Trifluridine Tipiramidine Tablets, Lurasidone Hydrochloride Tablets, and Polymyxin E Sodium Mesylate for Injection Over-evaluation of product regulations; Yuandong Bio has five batches of over-evaluation including repaglinide metformin tablets (I), repaglinide metformin tablets (II), and naloxone hydrochloride injection
    .
    In 2022, the first batch of products that passed the quality and efficacy consistency evaluation of generic drugs are listed on the Internet for details (partial) Please refer to the relevant data download below for details.
    Disclaimer: In any case, the information or opinions expressed in this article do not constitute a Investment advice from anyone
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.